SOPHIA GENETICS SA |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.03 USD | +1.62% |
|
+1.41% | +6.79% |
| Apr. 23 | Sophia Genetics Says Nigeria's Syndicate Bio Signs on to Implement Liquid Biopsy Offering | MT |
| Apr. 23 | SOPHiA GENETICS Announces Syndicate Bio as First Liquid Biopsy Customer in Africa | CI |
Presenter SpeechJoshua Bowers (Analysts)Good morning, everyone. Welcome to JPMorgan Healthcare...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Sophia Genetics SA is a Switzerland-based company engaged in the software publishing sector. The Company offer a cloud-based Software-as-a-Service platform - the SOPHiA DDM, which is data-driven medicine platform enabling insights from disparate, complex datasets to improve diagnosis, treatment, and drug development. The Company has offices in Switzerland, France and the United Kingdom and operates worldwide.
Sector
Software
Calendar
2024-05-06
- Q1 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
5.03
USD
Average target price
8.667
USD
Spread / Average Target
+72.30%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +6.79% | 328M | |
| +8.05% | 3,020B | |
| +5.58% | 82.93B | |
| +3.69% | 76.85B | |
| -14.62% | 53.04B | |
| +31.16% | 50.15B | |
| -24.56% | 46.55B | |
| +17.75% | 41.41B | |
| +55.21% | 35.63B | |
| -10.24% | 24.64B |
- Stock Market
- Equities
- SOPH Stock
- News SOPHiA GENETICS SA
- Transcript : SOPHiA GENETICS SA Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-11-2024 09
